BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38424455)

  • 1. Progesterone receptor potentiates macropinocytosis through CDC42 in pancreatic ductal adenocarcinoma.
    Liao YN; Gai YZ; Qian LH; Pan H; Zhang YF; Li P; Guo Y; Li SX; Nie HZ
    Oncogenesis; 2024 Feb; 13(1):10. PubMed ID: 38424455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A low amino acid environment promotes cell macropinocytosis through the YY1-FGD6 axis in Ras-mutant pancreatic ductal adenocarcinoma.
    Zhang YF; Li Q; Huang PQ; Su T; Jiang SH; Hu LP; Zhang XL; Sun Y; Pan H; Yang XM; Li J; Gai YZ; Zhu L; Yao LL; Li DX; Sun YW; Zhang ZG; Liu DJ; Zhang YL; Nie HZ
    Oncogene; 2022 Feb; 41(8):1203-1215. PubMed ID: 35082383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer.
    DiNorcia J; Lee MK; Moroziewicz DN; Winner M; Suman P; Bao F; Remotti HE; Zou YS; Yan SF; Qiu W; Su GH; Schmidt AM; Allendorf JD
    J Gastrointest Surg; 2012 Jan; 16(1):104-12; discussion 112. PubMed ID: 22052106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis.
    Bannoura SF; Aboukameel A; Khan HY; Uddin MH; Jang H; Beal E; Thangasamy A; Kim S; Wagner KU; Mohammad R; Al-Hallak MN; Pasche BC; Azmi AS
    bioRxiv; 2023 Dec; ():. PubMed ID: 38187605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dinaciclib prolongs survival in the
    Yang J; Hu S; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Benson Iii AB; Zhang Z
    Am J Transl Res; 2020; 12(3):1031-1043. PubMed ID: 32269732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderate alcohol intake promotes pancreatic ductal adenocarcinoma development in mice expressing oncogenic Kras.
    Asahina K; Balog S; Hwang E; Moon E; Wan E; Skrypek K; Chen Y; Fernandez J; Romo J; Yang Q; Lai K; French SW; Tsukamoto H
    Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G265-G276. PubMed ID: 31760766
    [No Abstract]   [Full Text] [Related]  

  • 7. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC.
    Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG
    Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasohibin-2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma.
    Iida-Norita R; Kawamura M; Suzuki Y; Hamada S; Masamune A; Furukawa T; Sato Y
    Cancer Sci; 2019 Jul; 110(7):2296-2308. PubMed ID: 31074083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and pharmacologic abrogation of Snail1 inhibits acinar-to-ductal metaplasia in precursor lesions of pancreatic ductal adenocarcinoma and pancreatic injury.
    Fendrich V; Jendryschek F; Beeck S; Albers M; Lauth M; Esni F; Heeger K; Dengler J; Slater EP; Holler JPN; Baier A; Bartsch DK; Waldmann J
    Oncogene; 2018 Apr; 37(14):1845-1856. PubMed ID: 29367759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive dynamic monitoring initiation and growth of pancreatic tumor in the LSL-Kras
    Hu S; Pan L; Shangguan J; Figini M; Eresen A; Sun C; Wang B; Ma Q; Hu C; Yaghmai V; Velichko Y; Yang J; Zhang Z
    J Immunol Methods; 2019 Feb; 465():1-6. PubMed ID: 30468734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
    Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma.
    Lakshmanan I; Marimuthu S; Chaudhary S; Seshacharyulu P; Rachagani S; Muniyan S; Chirravuri-Venkata R; Atri P; Rauth S; Nimmakayala RK; Siddiqui JA; Gautam SK; Shah A; Natarajan G; Parte S; Bhyravbhatla N; Mallya K; Haridas D; Talmon GA; Smith LM; Kumar S; Ganti AK; Jain M; Ponnusamy MP; Batra SK
    Oncogene; 2022 Nov; 41(48):5147-5159. PubMed ID: 36271032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin binding revitalizes NQO1 bioactivatable drugs as novel therapeutics for pancreatic cancer.
    Dou L; Liu H; Wang K; Liu J; Liu L; Ye J; Wang R; Deng H; Qian F
    J Control Release; 2022 Sep; 349():876-889. PubMed ID: 35907592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated expression profiling of potassium channels identifys KCNN4 as a prognostic biomarker of pancreatic cancer.
    Jiang S; Zhu L; Yang J; Hu L; Gu J; Xing X; Sun Y; Zhang Z
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):113-119. PubMed ID: 29050937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black raspberries suppress pancreatic cancer through modulation of NKp46
    Pan P; Zhu Z; Oshima K; Aldakkak M; Tsai S; Huang YW; Dong W; Zhang J; Lin CW; Wang Y; Yearsley M; Yu J; Wang LS
    Food Front; 2020 Mar; 1(1):70-82. PubMed ID: 32368735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell-based adoptive transfer immunotherapy for pancreatic ductal adenocarcinoma in a
    Hu S; Yang J; Shangguan J; Eresen A; Li Y; Ma Q; Yaghmai V; Velichko Y; Hu C; Zhang Z
    Am J Cancer Res; 2019; 9(8):1757-1765. PubMed ID: 31497356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
    Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
    Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR55 signalling promotes proliferation of pancreatic cancer cells and tumour growth in mice, and its inhibition increases effects of gemcitabine.
    Ferro R; Adamska A; Lattanzio R; Mavrommati I; Edling CE; Arifin SA; Fyffe CA; Sala G; Sacchetto L; Chiorino G; De Laurenzi V; Piantelli M; Sansom OJ; Maffucci T; Falasca M
    Oncogene; 2018 Dec; 37(49):6368-6382. PubMed ID: 30061636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.